-
1
-
-
0007492298
-
Biochemical studies on diphenhydramine (benadryl) distribution in tissues and urinary excretion
-
Glazko AJ, Dill WA. 1949. Biochemical studies on diphenhydramine (benadryl) distribution in tissues and urinary excretion. J Biol Chem 179(1):403-408.
-
(1949)
J Biol Chem
, vol.179
, Issue.1
, pp. 403-408
-
-
Glazko, A.J.1
Dill, W.A.2
-
2
-
-
33646765129
-
Biochemical studies on diphenhydramine (benadryl)
-
Glazko AJ, McGinty DA, Dill WA, Wilson ML, Ward CS. 1949. Biochemical studies on diphenhydramine (benadryl). J Biol Chem 179(1):409-416.
-
(1949)
J Biol Chem
, vol.179
, Issue.1
, pp. 409-416
-
-
Glazko, A.J.1
McGinty, D.A.2
Dill, W.A.3
Wilson, M.L.4
Ward, C.S.5
-
3
-
-
0023152732
-
Transport of diphenhydramine in the central nervous system
-
Goldberg MJ, Spector R, Chiang CK. 1987. Transport of diphenhydramine in the central nervous system. J Pharmacol Exp Ther 240(3):717-722.
-
(1987)
J Pharmacol Exp Ther
, vol.240
, Issue.3
, pp. 717-722
-
-
Goldberg, M.J.1
Spector, R.2
Chiang, C.K.3
-
4
-
-
4444311359
-
Steady-state brain concentrations of antihistamines in rats: Interplay of membrane permeability, P-glycoprotein efflux, and plasma protein binding
-
Mahar Doan KM, Wring SA, Shampine LJ, Jordan KH, Bishop JP, Kratz J, Yang E, Serabjit-Singh CJ, Adkison KK, Polli JW. 2004. Steady-state brain concentrations of antihistamines in rats: Interplay of membrane permeability, P-glycoprotein efflux, and plasma protein binding. Pharmacology 72(2):92-98.
-
(2004)
Pharmacology
, vol.72
, Issue.2
, pp. 92-98
-
-
Mahar, D.K.1
Wring, S.A.2
Shampine, L.J.3
Jordan, K.H.4
Bishop, J.P.5
Kratz, J.6
Yang, E.7
Serabjit-Singh, C.J.8
Adkison, K.K.9
Polli, J.W.10
-
5
-
-
33646788040
-
A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: Potential involvement of a carrier-mediated mechanism
-
Au-Yeung SC, Rurak DW, Gruber N, Riggs KW. 2006. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: Potential involvement of a carrier-mediated mechanism. Drug Metab Dispos 34(6):955-960.
-
(2006)
Drug Metab Dispos
, vol.34
, Issue.6
, pp. 955-960
-
-
Au-Yeung, S.C.1
Rurak, D.W.2
Gruber, N.3
Riggs, K.W.4
-
6
-
-
33747816123
-
In vivo blood-brain barrier transport of oxycodone in the rat: Indications for active influx and implications for pharmacokinetics/pharmacodynamics
-
Boström E, Simonsson US, Hammarlund-Udenaes M. 2006. In vivo blood-brain barrier transport of oxycodone in the rat: Indications for active influx and implications for pharmacokinetics/pharmacodynamics. Drug Metab Dispos 34(9):1624-1631.
-
(2006)
Drug Metab Dispos
, vol.34
, Issue.9
, pp. 1624-1631
-
-
Boström, E.1
Simonsson, U.S.2
Hammarlund-Udenaes, M.3
-
7
-
-
39749132196
-
Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine
-
Boström E, Hammarlund-Udenaes M, Simonsson US. 2008. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology 108(3):495-505.
-
(2008)
Anesthesiology
, vol.108
, Issue.3
, pp. 495-505
-
-
Boström, E.1
Hammarlund-Udenaes, M.2
Simonsson, U.S.3
-
8
-
-
38149118966
-
Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells
-
Kuwayama K, Inoue H, Kanamori T, Tsujikawa K, Miyaguchi H, Iwata Y, Miyauchi S, Kamo N, Kishi T. 2008. Uptake of 3, 4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells. Biochim Biophys Acta 1778(1):42-50.
-
(2008)
Biochim Biophys Acta
, vol.1778
, Issue.1
, pp. 42-50
-
-
Kuwayama, K.1
Inoue, H.2
Kanamori, T.3
Tsujikawa, K.4
Miyaguchi, H.5
Iwata, Y.6
Miyauchi, S.7
Kamo, N.8
Kishi, T.9
-
9
-
-
32244438135
-
Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells
-
Fischer W, Metzner L, Hoffmann K, Neubert RH, Brandsch M. 2006. Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells. Pharm Res 23(1):131-137.
-
(2006)
Pharm Res
, vol.23
, Issue.1
, pp. 131-137
-
-
Fischer, W.1
Metzner, L.2
Hoffmann, K.3
Neubert, R.H.4
Brandsch, M.5
-
10
-
-
52949145587
-
Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone
-
Okura T, Hattori A, Takano Y, Sato T, Hammarlund-Udenaes M, Terasaki T, Deguchi Y. 2008. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab Dispos 36(10):2005-2013.
-
(2008)
Drug Metab Dispos
, vol.36
, Issue.10
, pp. 2005-2013
-
-
Okura, T.1
Hattori, A.2
Takano, Y.3
Sato, T.4
Hammarlund-Udenaes, M.5
Terasaki, T.6
Deguchi, Y.7
-
12
-
-
0028182412
-
Transport mechanism of an H1-antagonist at the blood-brain barrier: Transport mechanism of mepyramine using the carotid injection technique
-
Yamazaki M, Fukuoka H, Nagata O, Kato H, Ito Y, Terasaki T, Tsuji A 1994. Transport mechanism of an H1-antagonist at the blood-brain barrier: Transport mechanism of mepyramine using the carotid injection technique. Biol Pharm Bull 17(5):676-679.
-
(1994)
Biol Pharm Bull
, vol.17
, Issue.5
, pp. 676-679
-
-
Yamazaki, M.1
Fukuoka, H.2
Nagata, O.3
Kato, H.4
Ito, Y.5
Terasaki, T.6
Tsuji, A.7
-
13
-
-
0028020780
-
Carrier-mediated transport of H1-antagonist at the blood-brain barrier: A common transport system of H1-antagonists and lipophilic basic drugs
-
Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, Tsuji A. 1994. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: A common transport system of H1-antagonists and lipophilic basic drugs. Pharm Res 11(11):1516-1518.
-
(1994)
Pharm Res
, vol.11
, Issue.11
, pp. 1516-1518
-
-
Yamazaki, M.1
Terasaki, T.2
Yoshioka, K.3
Nagata, O.4
Kato, H.5
Ito, Y.6
Tsuji, A.7
-
14
-
-
0028242852
-
Carrier-mediated transport of H1-antagonist at the blood-brain barrier: Mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures
-
Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, Tsuji A. 1994. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: Mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures. Pharm Res 11(7):975-978.
-
(1994)
Pharm Res
, vol.11
, Issue.7
, pp. 975-978
-
-
Yamazaki, M.1
Terasaki, T.2
Yoshioka, K.3
Nagata, O.4
Kato, H.5
Ito, Y.6
Tsuji, A.7
-
15
-
-
33746508758
-
Molecular cloning, functional characterization, and tissue distribution of rat H+/organic cation antiporter MATE1
-
Terada T, Masuda S, Asaka J, Tsuda M, Katsura T, Inui K. 2006. Molecular cloning, functional characterization, and tissue distribution of rat H+/organic cation antiporter MATE1. Pharm Res 23(8):1696-1701.
-
(2006)
Pharm Res
, vol.23
, Issue.8
, pp. 1696-1701
-
-
Terada, T.1
Masuda, S.2
Asaka, J.3
Tsuda, M.4
Katsura, T.5
Inui, K.6
-
16
-
-
33751106714
-
Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney
-
Ohta KY, Inoue K, Hayashi Y, Yuasa H. 2006. Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney. Drug Metab Dispos 34(11):1868-1874.
-
(2006)
Drug Metab Dispos
, vol.34
, Issue.11
, pp. 1868-1874
-
-
Ohta, K.Y.1
Inoue, K.2
Hayashi, Y.3
Yuasa, H.4
-
17
-
-
0025276155
-
High-performance liquid chromatography method for the determination of diphenhydramine in human plasma
-
Selinger K, Prevost J, Hill HM. 1990. High-performance liquid chromatography method for the determination of diphenhydramine in human plasma. J Chromatogr 526(2):597-602.
-
(1990)
J Chromatogr
, vol.526
, Issue.2
, pp. 597-602
-
-
Selinger, K.1
Prevost, J.2
Hill, H.M.3
-
18
-
-
0026047885
-
Sensitive high-performance liquid chromatographic (HPLC) determination of diphenhydramine in plasma using fluorescence detection
-
Webb CL, Eldon MA. 1991. Sensitive high-performance liquid chromatographic (HPLC) determination of diphenhydramine in plasma using fluorescence detection. Pharm Res 8(11):1448-1451.
-
(1991)
Pharm Res
, vol.8
, Issue.11
, pp. 1448-1451
-
-
Webb, C.L.1
Eldon, M.A.2
-
19
-
-
8344236752
-
The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone, and noroxycodone in ringer solution, rat plasma, and rat brain tissue
-
Boström E, Jansson B, Hammarlund-Udenaes M, Simonsson US. 2004. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone, and noroxycodone in ringer solution, rat plasma, and rat brain tissue. Rapid Commun Mass Spectrom 18(21):2565-2576.
-
(2004)
Rapid Commun Mass Spectrom
, vol.18
, Issue.21
, pp. 2565-2576
-
-
Boström, E.1
Jansson, B.2
Hammarlund-Udenaes, M.3
Simonsson, U.S.4
-
20
-
-
0031786058
-
Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method
-
Bouw MR, Hammarlund-Udenaes M. 1998. Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method. Pharm Res 15(11):1673-1679.
-
(1998)
Pharm Res
, vol.15
, Issue.11
, pp. 1673-1679
-
-
Bouw, M.R.1
Hammarlund-Udenaes, M.2
-
21
-
-
52449106158
-
The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies
-
Bengtsson J, Boström E, Hammarlund-Udenaes M. 2008. The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies. J Pharm Sci 97(8):3433-3441.
-
(2008)
J Pharm Sci
, vol.97
, Issue.8
, pp. 3433-3441
-
-
Bengtsson, J.1
Boström, E.2
Hammarlund-Udenaes, M.3
-
22
-
-
45949107902
-
On the rate and extent of drug delivery to the brain
-
Hammarlund-Udenaes M, Friden M, Syvanen S, Gupta A. 2008. On the rate and extent of drug delivery to the brain. Pharm Res 25(8):1737-1750.
-
(2008)
Pharm Res
, vol.25
, Issue.8
, pp. 1737-1750
-
-
Hammarlund-Udenaes, M.1
Friden, M.2
Syvanen, S.3
Gupta, A.4
-
23
-
-
73949139927
-
Drug-drug interaction between oxycodone and adjuvant analgesics in blood-brain barrier transport and antinociceptive effect
-
Nakazawa Y, Okura T, Shimomura K, Terasaki T, Deguchi Y. 2010. Drug-drug interaction between oxycodone and adjuvant analgesics in blood-brain barrier transport and antinociceptive effect. J Pharm Sci 99(1):467-474.
-
(2010)
J Pharm Sci
, vol.99
, Issue.1
, pp. 467-474
-
-
Nakazawa, Y.1
Okura, T.2
Shimomura, K.3
Terasaki, T.4
Deguchi, Y.5
-
24
-
-
20344398703
-
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833
-
Boström E, Simonsson US, Hammarlund-Udenaes M. 2005. Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833. J Pharm Sci 94(5):1060-1066.
-
(2005)
J Pharm Sci
, vol.94
, Issue.5
, pp. 1060-1066
-
-
Boström, E.1
Simonsson, U.S.2
Hammarlund-Udenaes, M.3
-
25
-
-
0025353290
-
Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children
-
Simons KJ, Watson WT, Martin TJ, Chen XY, Simons FE. 1990. Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol 30(7):665-671.
-
(1990)
J Clin Pharmacol
, vol.30
, Issue.7
, pp. 665-671
-
-
Simons, K.J.1
Watson, W.T.2
Martin, T.J.3
Chen, X.Y.4
Simons, F.E.5
-
26
-
-
0021240623
-
Diphenhydramine disposition in chronic liver disease
-
Meredith CG, Christian, CDJr., Johnson RF, Madhavan SV, Schenker S. 1984. Diphenhydramine disposition in chronic liver disease. Clin Pharmacol Ther 35(4):474-479.
-
(1984)
Clin Pharmacol Ther
, vol.35
, Issue.4
, pp. 474-479
-
-
Meredith, C.G.1
Christian Jr, C.D.2
Johnson, R.F.3
Madhavan, S.V.4
Schenker, S.5
-
27
-
-
0026492647
-
Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer
-
Leow KP, Smith MT, Williams B, Cramond T. 1992. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther 52(5):487-495.
-
(1992)
Clin Pharmacol Ther
, vol.52
, Issue.5
, pp. 487-495
-
-
Leow, K.P.1
Smith, M.T.2
Williams, B.3
Cramond, T.4
-
28
-
-
56449127739
-
Plasma concentrations of oral oxycodone are greatly increased in the elderly
-
Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT. 2008. Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clin Pharmacol Ther 84(4):462-467.
-
(2008)
Clin Pharmacol Ther
, vol.84
, Issue.4
, pp. 462-467
-
-
Liukas, A.1
Kuusniemi, K.2
Aantaa, R.3
Virolainen, P.4
Neuvonen, M.5
Neuvonen, P.J.6
Olkkola, K.T.7
-
29
-
-
0027424888
-
Determination of the serum protein binding of oxycodone and morphine using ultrafiltration
-
Leow KP, Wright AW, Cramond T, Smith MT. 1993. Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit 15(5):440-447.
-
(1993)
Ther Drug Monit
, vol.15
, Issue.5
, pp. 440-447
-
-
Leow, K.P.1
Wright, A.W.2
Cramond, T.3
Smith, M.T.4
|